Antibody Design and Conjugation

One downside in using the endogenous amino acids for ADC development is a heavily dispersed drug-to-antibody ratio (DAR) caused by the non-uniform distribution of the conjugation sites, especially in the case of Lysine-based conjugations. https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm